By Michelle Benoit MD, M. Yvette Williams-Brown MD, Creighton Edwards MD
Gynecologic Oncology instruction manual presents a complete but concise, useful consultant for fellows, citizens, expert trainees, and clinicians within the analysis and administration of gynecologic cancers. The publication addresses the basics of gynecologic oncology, together with staging, surgical treatments, comorbidity analysis and administration, adjuvant cures together with chemotherapy and radiation, and survival and palliative care. With a spotlight on particular administration decision-making, the e-book presents the fundamental details had to advisor the clinician at the ward or within the hospital, together with medical research references, clinical comorbidity algorithms, and directed gynecologic melanoma workups and coverings. In a bullet aspect layout, the ebook presents the assets you want to meet the calls for of scientific administration in gynecologic melanoma care. Gynecologic Oncology instruction manual positive aspects: Covers all basics of gynecologic oncology together with, staging, surgical cures, comorbidity analysis and administration, adjuvant treatments, and history examine information Examines survivor care and palliative care practices comprises medical examine references, scientific comorbidity algorithms, and directed workups and coverings Written in bullet-point layout for speedy reference
Read Online or Download Gynecologic Oncology Handbook An Evidence-Based Clinical Guide PDF
Similar oncology books
Energy Balance and Gastrointestinal Cancer
The gastrointestinal song presents one of many specified structures the place a number of malignancies, together with adenocarcinoma of the pancreas, esophagus and colon are each one linked to weight problems. This detailed organization is roofed during this quantity of strength stability and melanoma from the epidemiologic, biologic and capability etiologic point of view.
Brain Metastases from Primary Tumors. Epidemiology, Biology, and Therapy
With an annual cost of greater than 12 million international diagnoses and seven. 6 million deaths, the societal and financial burden of melanoma can't be overstated. mind metastases are the commonest malignant tumors of the significant fearful process, but their prevalence seems to be expanding regardless of the development of melanoma cures.
Branching Process Models of Cancer
This quantity develops effects on non-stop time branching approaches and applies them to review fee of tumor development, extending vintage paintings at the Luria-Delbruck distribution. for this reason, the writer calculate the chance that mutations that confer resistance to therapy are current at detection and quantify the level of tumor heterogeneity.
- A Student's Pocket Companion: Fundamentals of Physics
- Vitamin D and Cancer
- Human Cell Culture: Cancer Cell Lines
- Cell Cycle Deregulation in Cancer
- Age-time patterns of cancer to be anticipated from exposure to general mutagens
- Counseling About Cancer: Strategies for Genetic Counseling
Additional resources for Gynecologic Oncology Handbook An Evidence-Based Clinical Guide
Example text
Monk BJ. Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study. J Clin Oncol. 2009;27(28): 4649–4655. 44. Duenas-Gonzales A. Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin vs. concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix. J Clin Oncol. 2011;29(13):1678–1685.
Symptoms include abdominal fullness, dyspepsia, constipation, tenesmus, pelvic fullness or pressure, bloating, anorexia, and electrolyte abnormalities (hypercalcemia). The route of spread for ovarian cancer is primarily transcoelomic. Cancer cells flake off the ovarian surface and implant throughout the abdomen and pelvis. Other routes of spread are lymphatic and hematogenous. II. The pretreatment workup includes a history and physical examination, lymph node (LN) survey, laboratory tests including a CBC, CMP, coagulation profile, CA-125, and other indicated tumor markers.
VI. Chemotherapy for epithelial ovarian cancer: latinum-sensitive and platinum-resistant disease. Platinum P resistance is defined as disease recurrence less than 6 months after DESIGN SERVICES OF OF 2C. Ovarian Cancer 45 completion of first-line platinum-based chemotherapy. If recurrence occurs at less than 6 months, non-platinum-based salvage therapies should be used; if greater than 6 months pass between completion of first-line platinum-based chemotherapy and recurrence, re-attempts with platinum-based regimens should be used.